The goal of the Clinical Core is to facilitate high quality clinical, neuropsychological, epidemiological and neuropathological research regarding Alzheimer's disease. Three considerations influenced the design of the proposed Core: the expertise of investigators at Rush, the establishment of a Memory Assessment Clinic at Cook County Hospital, and the success of the Religious Orders Study Core. These considerations led to a design that will recruit and follow very large numbers of cases and controls for clinical studies but a relatively small group for neuropathologic studies, and will emphasize enrollment of African American and Hispanic minorities. The Core proposes to perform uniform structured baseline evaluations and follow 1,750 persons with dementia who agree to a brief annual informant interview, 150 persons who agree to a detailed annual clinical evaluation and brain donation at death, and 250 controls who agree to an annual interview. This approach will provide investigators using Core resources a large pool of subjects who are potentially eligible for externally funded studies. This approach will allow the Clinical Core to continue to build on its record of success. During the past project period, more than 1,600 persons enrolled in the Core. Follow-up interviews were performed on more than 85%. Almost 500 persons participated in one or more of 14 externally funded clinical projects. In addition, the overall autopsy rate in the Core exceeds 80% (265 autopsies of 322 deaths). Brain tissue from almost 150 persons were used in externally funded studies. Core personnel facilitated 22 other funded projects. While minority enrollment in the Core and in studies using subjects from the Core are both in excess of 15%, the Memory Assessment Clinic at Cook County should greatly facilitate enrollment of additional minorities.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
2P30AG010161-11
Application #
6355999
Study Section
Special Emphasis Panel (ZAG1)
Project Start
2001-07-01
Project End
2006-06-30
Budget Start
Budget End
Support Year
11
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
McAninch, Elizabeth A; Rajan, Kumar B; Evans, Denis A et al. (2018) A Common DIO2 Polymorphism and Alzheimer Disease Dementia in African and European Americans. J Clin Endocrinol Metab 103:1818-1826
Power, Melinda C; Mormino, Elizabeth; Soldan, Anja et al. (2018) Combined neuropathological pathways account for age-related risk of dementia. Ann Neurol 84:10-22
Samieri, Cécilia; Morris, Martha-Clare; Bennett, David A et al. (2018) Fish Intake, Genetic Predisposition to Alzheimer Disease, and Decline in Global Cognition and Memory in 5 Cohorts of Older Persons. Am J Epidemiol 187:933-940
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25
Bennett, David A (2018) Lack of Benefit With Idalopirdine for Alzheimer Disease: Another Therapeutic Failure in a Complex Disease Process. JAMA 319:123-125
Kaur, Antarpreet; Edland, Steven D; Peavy, Guerry M (2018) The MoCA-Memory Index Score: An Efficient Alternative to Paragraph Recall for the Detection of Amnestic Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 32:120-124
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Lee, Catherine; Betensky, Rebecca A; Alzheimer's Disease Neuroimaging Initiative (2018) Time-to-event data with time-varying biomarkers measured only at study entry, with applications to Alzheimer's disease. Stat Med 37:914-932
Lamar, Melissa; Yu, Lei; Rubin, Leah H et al. (2018) APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement :

Showing the most recent 10 out of 786 publications